Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S5NN
|
|||
| Former ID |
DIB000748
|
|||
| Drug Name |
ABI-010
|
|||
| Synonyms |
ABI-287; ABI-328; Anticancer geldanamycin analogs, Abraxis; Anticancer geldanamycin analogs, American Bioscience; CY-214; HH-23; HH-24; Hsp90 inhibitors (cancer), Abraxis; Hsp90 inhibitors (cancer), American BioScience; Nab-ABI-328; Nab-17-AAG (cancer), Abraxis; Nab-17-AAG (cancer), American Bioscience; 17-AAG (albumin-bound nanoparticle, intravenous), Abraxis; 17-AAG (albumin-bound nanoparticle, intravenous), American BioScience
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Investigative | [1] | |
| Company |
American BioScience Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.